Response Biomedical Corp (OTCBB - OTCQB:RPBIF.OB)

Data as of Jan 29
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-9.3M-5.4M-5.3M-5.8M
Total Other Cash Flow453.8K-567.5K812.9K2.5M
Funds From Operations-7.5M-4.6M-3.3M-2.3M
Funds From/For Other Operating Expenses386.8K-2.0M1.3M-1.1M
Net Cash Flow - Operating Activities-7.9M-2.6M-4.6M-1.2M
InvestingCapital Expenditures-69.9K-107.1K-311.0K-190.2K
Net Cash Flow Investing-88.9K-107.1K-311.0K-190.2K
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction-258.8K-300.6K-332.0K0.00
Net Proceeds Stock Sale7.6M6.1M0.002.7M
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.000.000.00390.1K
Net Cash Flow - Financing7.4M5.8M-332.0K2.3M
Exchange RateEffect of Exchange Rate on Cash-59.0K------
Net Change In Cash-646.3K3.1M-5.3M852.1K

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.